I appreciated the time and care that Dr. Chiang took to personally talk to me, and I felt that we were in good hands. After several months he was able to confirm that Gabriel’s mutation was indeed on the new LCA gene, NMNAT1.
We are majority owned and supported by Centrillion Technologies, a Palo Alto, CA-based company that aspires to complete the work of the Human Genome Project and help scientists efficiently characterize and analyze large segments of the genome to power previously unimaginable breakthroughs in human health and the environment.
© 2024 Molecular Vision Laboratory. All Rights Reserved.